Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 24, 2024
Abstract
Periodontitis,
a
chronic
inflammatory
disease,
is
the
leading
cause
of
tooth
loss
in
adults
and
one
most
prevalent
complex
oral
conditions.
Oxidative
stress
induced
by
excessive
generation
reactive
oxygen
species
(ROS)
leads
to
periodontitis,
which
closely
associated
with
pathological
processes,
including
mitochondrial
dysfunction
periodontal
cells
local
immune
dysregulation.
However,
current
treatment
modalities
that
target
single
processes
have
limited
long‐term
therapeutic
effects.
Herein,
multifunctional
Yolk–Shell
nanozyme,
Au@CeO
2
‐dimethyl
fumarate
(DMF),
comprehensively
addresses
oxidative
stress‐induced
pathophysiological
periodontitis
through
antioxidant
activity,
maintenance,
modulation
mechanisms,
described.
For
material
design
logic,
functionally
complementary
Au
CeO
formed
an
excellent
photothermally
regulated
high‐efficiency
also
provided
ideal
drug
carrier
for
DMF.
As
‐DMF
restores
dysregulation,
contributes
endogenous
ROS
elimination,
thereby
achieving
stable
In
rat
model,
photothermal
therapy
effectively
alleviated
ROS‐induced
tissue
damage
restored
homeostasis.
Altogether,
this
study
presents
novel
nanozyme
managing
alveolar
bone
under
prolonged
demonstrates
importance
comprehensive
intervention
key
design.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
14(11), P. 4683 - 4716
Published: Sept. 2, 2024
About
40%
of
approved
drugs
and
nearly
90%
drug
candidates
are
poorly
water-soluble
drugs.
Low
solubility
reduces
the
drugability.
Effectively
improving
bioavailability
is
a
critical
issue
that
needs
to
be
urgently
addressed
in
development
application.
This
review
briefly
introduces
conventional
solubilization
techniques
such
as
solubilizers,
hydrotropes,
cosolvents,
prodrugs,
salt
modification,
micronization,
cyclodextrin
inclusion,
solid
dispersions,
details
crystallization
strategies,
ionic
liquids,
polymer-based,
lipid-based,
inorganic-based
carriers
bioavailability.
Some
most
commonly
used
carrier
materials
for
presented.
Several
using
summarized.
Furthermore,
this
summarizes
mechanism
each
technique,
reviews
latest
research
advances
challenges,
evaluates
potential
clinical
translation.
could
guide
selection
approach,
dosage
form,
administration
route
Moreover,
we
discuss
several
promising
attracting
increasing
attention
worldwide.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
11(6)
Published: Dec. 8, 2023
Abstract
Rheumatoid
arthritis
(RA)
is
a
chronic
autoimmune
disease
featuring
an
abnormal
immune
microenvironment
and
resultant
accumulation
of
hydrogen
ions
(H
+
)
produced
by
activated
osteoclasts
(OCs).
Currently,
clinic
RA
therapy
can
hardly
achieve
sustained
or
efficient
therapeutic
outcomes
due
to
the
failures
in
generating
sufficient
modulation
manipulating
H
that
deteriorates
bone
damage.
Herein,
highly
effective
modulatory
nanocatalytic
platform,
nanoceria‐loaded
magnesium
aluminum
layered
double
hydroxide
(LDH‐CeO
2
),
proposed
for
enhanced
based
on
acid
neutralization
metal
ion
inherent
bioactivity.
Specifically,
mild
alkaline
LDH
initiates
significant
M2
repolarization
macrophages
triggered
elevated
antioxidation
effect
CeO
via
neutralizing
excessive
microenvironment,
thus
resulting
recruitment
regulatory
T
cell
(Treg)
suppressions
helper
17
(Th
17)
plasma
cells.
Moreover,
osteogenic
activity
stimulated
Mg
released
from
LDH,
thereby
promoting
damaged
healing.
The
encouraging
adjuvant‐induced
model
mice
demonstrate
high
feasibility
such
concept,
which
provides
novel
modality
bone‐repairing
effects
inorganic
material.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
Age‐related
macular
degeneration
(AMD),
characterized
by
choroidal
neovascularization
(CNV),
is
the
global
leading
cause
of
irreversible
blindness.
Current
first‐line
therapeutics,
vascular
endothelial
growth
factor
(VEGF)
antagonists,
often
yield
incomplete
and
suboptimal
vision
improvement,
necessitating
exploration
novel
efficacious
therapeutic
approaches.
Herein,
a
supramolecular
engineering
strategy
to
construct
moringin
(MOR)
loaded
α‐cyclodextrin
(α‐CD)
coated
nanoceria
(M@CCNP)
constructed,
where
hydroxy
newly
formed
carbonyl
groups
α‐CD
interact
with
surface
via
O─Ce
conjunction
isothiocyanate
group
MOR
inserts
deeply
into
cavity
host–guest
interaction.
By
exploiting
recycling
reactive
oxygen
species
(ROS)
scavenging
capability
anti‐inflammation
properties
MOR,
two‐level
strike
during
AMD
pathogenesis
can
be
precisely
blocked
M@CCNP.
Remarkably,
excellent
efficacy
CNV
observed
in
vivo,
achieving
over
80%
reduction
60%
leakage
area.
In
summary,
engineered
provides
an
efficient
approach
for
amelioration
blocking
strike,
presents
significant
potential
as
exceptional
drug
delivery
platform,
particularly
ROS‐related
diseases.
BME Frontiers,
Journal Year:
2025,
Volume and Issue:
6
Published: Jan. 1, 2025
Rheumatoid
arthritis
(RA)
is
a
systemic
inflammatory
autoimmune
disease
characterized
by
joint
swelling
and
bone
destruction.
Despite
an
incomplete
understanding
of
its
genesis,
RA
tightly
linked
to
the
intricate
immunological
milieu,
involving
disruptions
in
molecular
signaling
imbalance
between
innate
adaptive
immune
systems.
With
advancements
biomaterials
science,
role
treatment
has
evolved
from
mere
drug
delivery
systems
therapeutic
microenvironment
modulators,
providing
drug-independent
strategies
for
RA.
In
this
review,
we
will
delve
into
RA,
focusing
on
contributions
immunity,
damage-associated
patterns
(DAMPs),
cytokines,
pathways
disease’s
pathogenesis
inflammation.
We
provide
detailed
analysis
applications
novel
nonpharmaceutical
treatment,
categorized
3
key
mechanisms:
biofactor
pathway
regulation,
endogenous
gas
adjustment,
cell
modulation.
The
composition,
form,
principles,
efficacy
these
be
explored.
thorough
discussion
topics
offer
fresh
viewpoint
guide
future
research
directions.
British Journal of Haematology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Summary
Immune
thrombocytopenia
(ITP)
is
an
autoimmune
disorder
characterized
by
antiplatelet
autoantibodies,
with
many
patients
refractory
or
relapsing
on
conventional
treatments.
GPIbα,
important
autoantigen
in
ITP,
notably
linked
to
refractoriness,
highlighting
the
need
for
novel
We
assessed
CD19
chimeric
antigen
receptor
(CAR)‐T
cell
therapy's
potential
a
modified
murine
model
targeting
GPIbα.
CAR‐T
infusion
accelerated
platelet
count
recovery
compared
control
group,
effectively
depleted
+
B
cells
and
CD138
plasma
cells,
markedly
reduced
anti‐GPIbα
autoantibodies
vivo.
In
vitro
both
spleens
of
mice
ITP
patients.
therapy
significantly
altered
T‐cell
subsets,
increasing
regulatory
T
helper
1
17
populations,
suggesting
role
modulating
immune
response
sustained
remission.
Monitoring
body/spleen
weights
temperature
showed
no
significant
cytokine
release
syndrome,
indicating
favourable
safety
profile.
These
promising
results
support
as
treatment
option
particularly
GPIbα‐positive
autoantibody
Further
clinical
studies
are
warranted
assess
efficacy
this
approach
human
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 22, 2025
Abstract
Bacterial
keratitis
(BK)
is
a
type
of
corneal
inflammation
resulting
from
bacterial
infection
in
the
eye.
Although
nanozymes
have
been
explored
as
promising
materials
wound
healing,
currently
available
lack
sufficient
catalytic
activity
and
ability
to
penetrate
biofilms,
limiting
their
efficacy
against
treatment
BK.
To
remedy
this,
ZnFe
layered
double
hydroxide
(ZnFe‐LDH)
nanosheets
are
loaded
with
Cu
single‐atom
(Cu‐SAzymes)
aminated
dextran
(Dex‐NH
2
),
formation
nanozyme
DT‐ZnFe‐LDH@Cu,
which
possesses
peroxidase
(POD)‐,
oxidase
(OXD)‐,
catalase
(CAT)‐like
activities.
This
enables
generate
reactive
oxygen
species
(ROS),
such
hydroxyl
radicals
(
•
OH),
superoxide
anion
radical
(O
•−
singlet
1
O
)
hydrogen
peroxide
(H
thereby
killing
bacteria
causing
infections.
The
surface
Dex‐NH
enabled
DT‐ZnFe‐LDH@Cu
biofilm
adsorb
onto
extracellular
polymeric
substances
(EPS)
produced
by
biofilm.
Additionally,
successfully
repaired
P.
aeruginosa
‐infected
injury
BK
rabbit
model
more
effectively
than
commercially
tobramycin
eye
drops.
was
enabled,
part,
reduce
promoting
polarization
pro‐inflammatory
macrophages
(M1)
anti‐inflammatory
(M2)
decrease
expression
α‐smooth
muscle
actin
(α‐SMA)
promote
healing
without
scar
formation.
study
provides
an
innovative
concept
for
holds
great
scientific
value
clinical
application
potential.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
14(11), P. 4665 - 4682
Published: Sept. 14, 2024
Aluminum
adjuvants
(Alum),
approved
by
the
US
Food
and
Drug
Administration,
have
been
extensively
used
in
vaccines
containing
recombinant
antigens,
subunits
of
pathogens,
or
toxins
for
almost
a
century.
While
Alums
typically
elicit
strong
humoral
immune
responses,
their
ability
to
induce
cellular
mucosal
immunity
is
limited.
As
an
alternative,
layered
double
hydroxide
(LDH),
widely
antacid,
has
emerged
as
novel
class
potent
nano-aluminum
(NanoAlum),
demonstrating
advantageous
physicochemical
properties,
biocompatibility
adjuvanticity
both
responses.
In
this
review,
we
summarize
compare
advantages
disadvantages
Alum
NanoAlum
these
properties
performance
adjuvants.
Moreover,
propose
key
features
ideal
demonstrate
that
LDH
promising
candidate
summarizing
its
current
progress
immunotherapeutic
cancer
treatments.
Finally,
conclude
review
offering
our
integrated
perspectives
about
remaining
challenges
future
directions
NanoAlum's
application
preclinical/clinical
settings.